To get the latest updates about WORLDBI
AND YES! We hate spam too!!
Click here to navigate where you left last time
Wednesday 05th August 2020
COVID-19 pandemic is caused by a newly-discovered coronavirus, SARS-Cov-2. To characterize and detect this new virus, reagents, such as antibodies and antigens, to support scientific research, diagnosis and vaccine development are in urgent need. Sino Biological Inc uses internally-optimized HEK293 cells and other hosts to express S antigens with binding activity to ACE2, and also develops specific S and N antibodies to SARS-Cov-2 by several antibody generation platforms. Meanwhile, antibodies which have cross-reactivity to other strains of coronaviruses are under development and validation
Director of R&DSino Biological Inc.
Sino Biological is an international reagent supplier and service provider. The company specializes in
recombinant antigen production and antibody development. The company’s ever-growing portfolio
of products includes recombinant proteins, monoclonal antibodies, ELISA assay kits, expression
clones, cell culture media, and other molecular biology tools. The company also offers a variety of
customized services, mainly focusing on recombinant production of antigens and antibodies. Sino
Biological is dedicated to virology and infectious disease research. Its newly launched ProVirTM
collection is the world’s largest viral antigen bank, carrying over 800 products from 350 strains of